In a world where the… Alzheimer is one of the most feared neurodegenerative diseases, according to a recent study published in Natural aging opens a window of hope. Researchers from the UK and China have developed one Blood test are able to predict the onset of these and other dementias up to a decade before their clinical diagnosis. This finding represents scientific progress and also an opportunity for preventative medicine.
YOU CAN SEE: Which Latin American country is investing millions of dollars in lingerie from Peru?
Researchers from the United Kingdom and China have developed a blood test that can predict the onset of Alzheimer's disease. Photo: AFP
This test, based on identifying specific proteins in the blood, could change the current approach to dementia treatment and research. The possibility of early detection opens the possibility of intervening before the disease progresses, thereby opening the door to more effective therapies and preventive measures.
YOU CAN SEE: Girl was born without eyes despite tests showing no condition: she is one of 30 cases in the world
What is the blood test about?
The study published in Nature Aging analyzed more than 50,000 blood samples, Identification of proteins that serve as predictive biomarkers for dementia. This test stands out for its accessibility and cost-effectiveness compared to traditional diagnostic methods such as brain scans. Detecting these proteins at early stages could facilitate surveillance and preventive intervention in people at high risk for development Alzheimer and other dementias.
YOU CAN SEE: Biden accuses Putin: “He is responsible for Navalny’s death, make no mistake”
Some factors of the study
The research focused on analyzing frozen blood samples, which identified 1,463 proteins linked to the risk of developing dementia. These biomarkers provide a unique window into understanding the underlying processes that lead to disease long before symptoms manifest.
The relevance of this study lies in its potential to predict the onset of dementia and also in its contribution to the development of targeted therapeutic strategies. By identifying people at risk years before the onset of the disease, it is possible to focus research efforts on prevention and the search for more effective treatments.
Alzheimer's is a progressive neurodegenerative disease that affects memory. Photo: AFP
YOU CAN SEE: Does artificial intelligence improve or impact public employment in Latin America?
What is Alzheimer's?
Alzheimer's is a progressive neurodegenerative disease that affects memory, thinking and the ability to carry out everyday activities. It is the most common cause of dementia in older people. The disease is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain, leading to the death of brain cells. The symptoms begin gradually and worsen over time, significantly affecting the independence and quality of life of those affected.